menu
    • menu
    [{"orgOrder":0,"company":"International Flavors and Fragrances","sponsor":"MRM Health","pharmaFlowCategory":"D","therapeuticArea":"Endocrinology","country":"U.S.A","productType":"Large molecule","year":"2020","type":"Collaboration","leadProduct":"Gut microbiome based therapeutics","moa":"","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"International Flavors and Fragrances","amount2":0.02,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0.02,"dosageForm":"","sponsorNew":"International Flavors and Fragrances \/ DuPont","highestDevelopmentStatusID":"1","companyTruncated":"International Flavors and Fragrances \/ DuPont"},{"orgOrder":0,"company":"International Flavors and Fragrances","sponsor":"International Flavors and Fragrances","pharmaFlowCategory":"D","therapeuticArea":"Immunology","country":"U.S.A","productType":"Large molecule","year":"2020","type":"Collaboration","leadProduct":"Gut-Microbiome","moa":"","graph1":"Immunology","graph2":"Discovery","graph3":"International Flavors and Fragrances","amount2":0,"highestDevelopmentShortName":"Discovery","therapeuticAreaShortName":"Immunology","amount2New":0,"dosageForm":"","sponsorNew":"International Flavors and Fragrances \/ DuPont","highestDevelopmentStatusID":"2","companyTruncated":"International Flavors and Fragrances \/ DuPont"}]

    Find Clinical Drug Pipeline Developments & Deals by International Flavors and Fragrances

    Menu

    International Flavors and Fragrances

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            International Flavors and Fragrances

                            U.S.A arrow
                            Pharmtech & Ingredients
                            Not Confirmed

                            International Flavors and Fragrances

                            U.S.A arrow
                            Pharmtech & Ingredients
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Gut-Microbiome

                            Therapeutic Area : Immunology

                            Study Phase : Discovery

                            Recipient : Rutgers University

                            Deal Size : Undisclosed

                            Deal Type : Collaboration

                            DEALS_DEV arrow-down

                            DuPont Nutrition & Biosciences Announces Research Collaboration with Rutgers University

                            Details : The two-year research partnership will focus on improving the benefit/risk ratio of chemotherapy by decreasing gut inflammation caused by chemotherapy to potentially improve response rates through modulation of the microbiome.

                            Brand Name : Undisclosed

                            Molecule Type : Large molecule

                            Upfront Cash : Undisclosed

                            July 23, 2020

                            Lead Product(s) : Gut-Microbiome

                            Therapeutic Area : Immunology

                            Highest Development Status : Discovery

                            Recipient : Rutgers University

                            Deal Size : Undisclosed

                            Deal Type : Collaboration

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            International Flavors and Fragrances

                            U.S.A arrow
                            Pharmtech & Ingredients
                            Not Confirmed

                            International Flavors and Fragrances

                            U.S.A arrow
                            Pharmtech & Ingredients
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Gut microbiome based therapeutics

                            Therapeutic Area : Endocrinology

                            Study Phase : Undisclosed

                            Recipient : MRM Health

                            Deal Size : $15.1 million

                            Deal Type : Collaboration

                            DEALS_DEV arrow-down

                            DuPont Nutrition & Biosciences Enters into Collaboration

                            Details : In collaboration, proprietary MRM Health technology platform and some selected DuPont strains will be combined to develop novel therapeutics based on live bacterial strain combinations.

                            Brand Name : Undisclosed

                            Molecule Type : Large molecule

                            Upfront Cash : Undisclosed

                            February 19, 2020

                            Lead Product(s) : Gut microbiome based therapeutics

                            Therapeutic Area : Endocrinology

                            Highest Development Status : Undisclosed

                            Recipient : MRM Health

                            Deal Size : $15.1 million

                            Deal Type : Collaboration

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth